stage 1 glp GLP-1 patients aren't approaching aesthetics the same way—and providers can't treat them as one segment. Budget flexibility and aesthetic goals are increasingly shaping treatment pathways alongside medical factors like weight-loss and Gestalt Language Handout | TPT

10.1124/mol.104.004465 134 StoccoroA.SicilianoG.MiglioreL.CoppedeF

These weight-loss and metabolic disease therapies now rank in the top 5 global pharmaceuticals by revenue, underscoring how the GLP-1 new drug wave is reshaping Big Pharmas rankings

Cook similar to vegetables, add to soups or steam lightly for daily meals

An analysis of the FDA Adverse Event Reporting System (collecting worldwide adverse events) identified an increased reporting odds ratio for alopecia with semaglutide and tirzepatide, while no significant increase was observed for liraglutide, dulaglutide, exenatide, or lixisenatide [81]

[It] ensures uninterrupted supply of medications ( [17] )